Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Provisional standardization of hepcidin assays: creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material.

Diepeveen LE, Laarakkers CMM, Martos G, Pawlak ME, Uğuz FF, Verberne KESA, van Swelm RPL, Klaver S, de Haan AFJ, Pitts KR, Bansal SS, Abbas IM, Fillet M, Lefebvre T, Geurts-Moespot AJ, Girelli D, Castagna A, Herkert M, Itkonen O, Olbina G, Tomosugi N, Westerman ME, Delatour V, Weykamp CW, Swinkels DW.

Clin Chem Lab Med. 2019 May 27;57(6):864-872. doi: 10.1515/cclm-2018-0783.

PMID:
30485171
2.

Differential assay reactivity of immunglobulin A anti-ß2 glycoprotein I antibodies: implications for the clinical interpretation of antiphospholipid antibody testing.

Hood DB, Snyder KR, Buckner TR, Hurley BL, Pitts KR, Lopez LR.

Eur J Rheumatol. 2015 Dec;2(4):135-138. Epub 2015 Aug 21.

3.

Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.

Cross RW, Boisen ML, Millett MM, Nelson DS, Oottamasathien D, Hartnett JN, Jones AB, Goba A, Momoh M, Fullah M, Bornholdt ZA, Fusco ML, Abelson DM, Oda S, Brown BL, Pham H, Rowland MM, Agans KN, Geisbert JB, Heinrich ML, Kulakosky PC, Shaffer JG, Schieffelin JS, Kargbo B, Gbetuwa M, Gevao SM, Wilson RB, Saphire EO, Pitts KR, Khan SH, Grant DS, Geisbert TW, Branco LM, Garry RF.

J Infect Dis. 2016 Oct 15;214(suppl 3):S210-S217. Epub 2016 Aug 31.

4.

Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.

Boisen ML, Cross RW, Hartnett JN, Goba A, Momoh M, Fullah M, Gbakie M, Safa S, Fonnie M, Baimba F, Koroma VJ, Geisbert JB, McCormick S, Nelson DK, Millett MM, Oottamasathien D, Jones AB, Pham H, Brown BL, Shaffer JG, Schieffelin JS, Kargbo B, Gbetuwa M, Gevao SM, Wilson RB, Pitts KR, Geisbert TW, Branco LM, Khan SH, Grant DS, Garry RF.

J Infect Dis. 2016 Oct 15;214(suppl 3):S203-S209. Epub 2016 Aug 11.

5.

An Outbreak of Ebola Virus Disease in the Lassa Fever Zone.

Goba A, Khan SH, Fonnie M, Fullah M, Moigboi A, Kovoma A, Sinnah V, Yoko N, Rogers H, Safai S, Momoh M, Koroma V, Kamara FK, Konowu E, Yillah M, French I, Mustapha I, Kanneh F, Foday M, McCarthy H, Kallon T, Kallon M, Naiebu J, Sellu J, Jalloh AA, Gbakie M, Kanneh L, Massaly JL, Kargbo D, Kargbo B, Vandi M, Gbetuwa M, Gevao SM, Sandi JD, Jalloh SC, Grant DS, Blyden SO, Crozier I, Schieffelin JS, McLellan SL, Jacob ST, Boisen ML, Hartnett JN, Cross RW, Branco LM, Andersen KG, Yozwiak NL, Gire SK, Tariyal R, Park DJ, Haislip AM, Bishop CM, Melnik LI, Gallaher WR, Wimley WC, He J, Shaffer JG, Sullivan BM, Grillo S, Oman S, Garry CE, Edwards DR, McCormick SJ, Elliott DH, Rouelle JA, Kannadka CB, Reyna AA, Bradley BT, Yu H, Yenni RE, Hastie KM, Geisbert JB, Kulakosky PC, Wilson RB, Oldstone MB, Pitts KR, Henderson LA, Robinson JE, Geisbert TW, Saphire EO, Happi CT, Asogun DA, Sabeti PC, Garry RF; Viral Hemorrhagic Fever Consortium.

J Infect Dis. 2016 Oct 15;214(suppl 3):S110-S121. Epub 2016 Jul 11.

6.

Toward Worldwide Hepcidin Assay Harmonization: Identification of a Commutable Secondary Reference Material.

van der Vorm LN, Hendriks JC, Laarakkers CM, Klaver S, Armitage AE, Bamberg A, Geurts-Moespot AJ, Girelli D, Herkert M, Itkonen O, Konrad RJ, Tomosugi N, Westerman M, Bansal SS, Campostrini N, Drakesmith H, Fillet M, Olbina G, Pasricha SR, Pitts KR, Sloan JH, Tagliaro F, Weykamp CW, Swinkels DW.

Clin Chem. 2016 Jul;62(7):993-1001. doi: 10.1373/clinchem.2016.256768. Epub 2016 May 12.

7.

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits.

Robinson JE, Hastie KM, Cross RW, Yenni RE, Elliott DH, Rouelle JA, Kannadka CB, Smira AA, Garry CE, Bradley BT, Yu H, Shaffer JG, Boisen ML, Hartnett JN, Zandonatti MA, Rowland MM, Heinrich ML, Martínez-Sobrido L, Cheng B, de la Torre JC, Andersen KG, Goba A, Momoh M, Fullah M, Gbakie M, Kanneh L, Koroma VJ, Fonnie R, Jalloh SC, Kargbo B, Vandi MA, Gbetuwa M, Ikponmwosa O, Asogun DA, Okokhere PO, Follarin OA, Schieffelin JS, Pitts KR, Geisbert JB, Kulakoski PC, Wilson RB, Happi CT, Sabeti PC, Gevao SM, Khan SH, Grant DS, Geisbert TW, Saphire EO, Branco LM, Garry RF.

Nat Commun. 2016 May 10;7:11544. doi: 10.1038/ncomms11544.

8.

Development of Prototype Filovirus Recombinant Antigen Immunoassays.

Boisen ML, Oottamasathien D, Jones AB, Millett MM, Nelson DS, Bornholdt ZA, Fusco ML, Abelson DM, Oda S, Hartnett JN, Rowland MM, Heinrich ML, Akdag M, Goba A, Momoh M, Fullah M, Baimba F, Gbakie M, Safa S, Fonnie R, Kanneh L, Cross RW, Geisbert JB, Geisbert TW, Kulakosky PC, Grant DS, Shaffer JG, Schieffelin JS, Wilson RB, Saphire EO, Branco LM, Garry RF, Khan SH, Pitts KR; Viral Hemorrhagic Fever Consortium.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S359-67. doi: 10.1093/infdis/jiv353. Epub 2015 Jul 30.

9.

Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak.

Boisen ML, Schieffelin JS, Goba A, Oottamasathien D, Jones AB, Shaffer JG, Hastie KM, Hartnett JN, Momoh M, Fullah M, Gabiki M, Safa S, Zandonatti M, Fusco M, Bornholdt Z, Abelson D, Gire SK, Andersen KG, Tariyal R, Stremlau M, Cross RW, Geisbert JB, Pitts KR, Geisbert TW, Kulakoski P, Wilson RB, Henderson L, Sabeti PC, Grant DS, Garry RF, Saphire EO, Branco LM, Khan SH; Viral Hemorrhagic Fever Consortium.

Viral Immunol. 2015 Feb;28(1):19-31. doi: 10.1089/vim.2014.0108.

10.

Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease.

Lopez LR, Guyer KE, Torre IG, Pitts KR, Matsuura E, Ames PR.

World J Diabetes. 2014 Apr 15;5(2):115-27. doi: 10.4239/wjd.v5.i2.115. Review.

11.

Lassa fever in post-conflict sierra leone.

Shaffer JG, Grant DS, Schieffelin JS, Boisen ML, Goba A, Hartnett JN, Levy DC, Yenni RE, Moses LM, Fullah M, Momoh M, Fonnie M, Fonnie R, Kanneh L, Koroma VJ, Kargbo K, Ottomassathien D, Muncy IJ, Jones AB, Illick MM, Kulakosky PC, Haislip AM, Bishop CM, Elliot DH, Brown BL, Zhu H, Hastie KM, Andersen KG, Gire SK, Tabrizi S, Tariyal R, Stremlau M, Matschiner A, Sampey DB, Spence JS, Cross RW, Geisbert JB, Folarin OA, Happi CT, Pitts KR, Geske FJ, Geisbert TW, Saphire EO, Robinson JE, Wilson RB, Sabeti PC, Henderson LA, Khan SH, Bausch DG, Branco LM, Garry RF; Viral Hemorrhagic Fever Consortium.

PLoS Negl Trop Dis. 2014 Mar 20;8(3):e2748. doi: 10.1371/journal.pntd.0002748. eCollection 2014 Mar.

12.

Screening and identification of a novel class of TGF-β type 1 receptor kinase inhibitor.

Huynh QK, Wise SJ, Koch KA, Castonguay LA, Reid BG, Pagratis EE, Koditek D, Glascock CB, Pitts KR, Turner BA, Liu X, Hung M, Han B, Pagratis N.

J Biomol Screen. 2011 Aug;16(7):724-33. doi: 10.1177/1087057111405846. Epub 2011 Apr 26.

PMID:
21521800
13.

Darusentan is a potent inhibitor of endothelin signaling and function in both large and small arteries.

Liang F, Glascock CB, Schafer DL, Sandoval J, Cable L, Melvin L Jr, Hartman JC, Pitts KR.

Can J Physiol Pharmacol. 2010 Aug;88(8):840-9. doi: 10.1139/Y10-061.

14.

Agonist-induced nuclear export of GFP-HDAC5 in isolated adult rat ventricular myocytes.

Peng Y, Lambert AA, Papst P, Pitts KR.

J Pharmacol Toxicol Methods. 2009 May-Jun;59(3):135-40. doi: 10.1016/j.vascn.2009.03.002. Epub 2009 Mar 26.

PMID:
19328241
15.

Endothelin receptor antagonism in portal hypertension.

Pitts KR.

Expert Opin Investig Drugs. 2009 Feb;18(2):135-42. doi: 10.1517/13543780802680186 . Review.

PMID:
19236261
16.
17.

Differentially regulated functional gene clusters identified during ischemia and reperfusion in isolated cardiac myocytes using coverslip hypoxia.

Pitts KR, Derry JM, Kerkof K, Lawrence WA, Toombs CF.

J Pharmacol Toxicol Methods. 2008 Jan-Feb;57(1):42-51. Epub 2007 Sep 19.

PMID:
17928241
18.

A phosphorimager-based filter binding thyroid hormone receptor competition assay for chemical screening.

Chapo J, Peng Y, Pitts KR.

J Pharmacol Toxicol Methods. 2007 Jul-Aug;56(1):28-33. Epub 2006 Dec 22.

PMID:
17276701
19.

Washout of heme-containing proteins dramatically improves tetrazolium-based infarct staining.

Pitts KR, Stiko A, Buetow B, Lott F, Guo P, Virca D, Toombs CF.

J Pharmacol Toxicol Methods. 2007 Mar-Apr;55(2):201-8. Epub 2006 Jul 7.

PMID:
16931060
20.

Mitochondria-specific function of the dynamin family protein DLP1 is mediated by its C-terminal domains.

Pitts KR, McNiven MA, Yoon Y.

J Biol Chem. 2004 Nov 26;279(48):50286-94. Epub 2004 Sep 13.

21.

Coverslip hypoxia: a novel method for studying cardiac myocyte hypoxia and ischemia in vitro.

Pitts KR, Toombs CF.

Am J Physiol Heart Circ Physiol. 2004 Oct;287(4):H1801-12. Epub 2004 May 20.

22.

Mammalian dynamin-like protein DLP1 tubulates membranes.

Yoon Y, Pitts KR, McNiven MA.

Mol Biol Cell. 2001 Sep;12(9):2894-905.

23.

Studying cytoskeletal dynamics in living cells using green fluorescent protein.

Yoon Y, Pitts KR, McNiven MA.

Methods Mol Biol. 2001;161:151-63. Review. No abstract available.

PMID:
11190503
24.

The dynamin family of mechanoenzymes: pinching in new places.

McNiven MA, Cao H, Pitts KR, Yoon Y.

Trends Biochem Sci. 2000 Mar;25(3):115-20. Review.

PMID:
10694881
25.
27.
28.

A kinetic study of iron release from Azotobacter vinelandii bacterial ferritin.

Richards TD, Pitts KR, Watt GD.

J Inorg Biochem. 1996 Jan;61(1):1-13.

PMID:
8558133

Supplemental Content

Loading ...
Support Center